Literature DB >> 19379896

Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T.

J Darcy O'Brien1, Susan E Howlett, Hayley J Burton, Stacey B O'Blenes, D Sharon Litz, Camille L Hancock Friesen.   

Abstract

BACKGROUND: Pediatric myocardium is unique from mature myocardium; thus, the use of adult cardioplegia for pediatric cardiac operations may provide suboptimal myocardial protection. We evaluated our standard adult cardioplegia (AC; modified Buckberg) and a pediatric cardioplegia (PC) solution (del Nido solution, Baxter) in vitro in rat cardiomyocytes and compared short-term outcomes in pediatric cardiac surgical patients.
METHODS: Contractions, intracellular calcium, and action potentials were recorded from isolated rat cardiomyocytes exposed to PC or AC, followed by reperfusion. Pediatric patients (n = 118) undergoing cardiac operations using PC (group PC, n = 59) or AC (group AC, n = 59) were matched 1:1 for age, diagnosis, and duration of cardiopulmonary bypass.
RESULTS: PC-perfused rat ventricular cardiomyocytes had lower diastolic calcium during cardioplegia and early reperfusion than AC-perfused cardiomyocytes. Cardiomyocytes remained excitable despite introduction of AC but not PC. The mean age in each pediatric group was 3.7 years (range, 3 days to 17 years; p = 0.95). Median serum troponin T levels at intensive care admission were significantly lower in group PC (0.83 +/- 0.25 microg/L) than in group AC (13.8 +/- 12.7 microg/L, p = 0.0001), which persisted at 24 hours postoperatively. There were no significant differences in duration of intubation or length of stay in intensive care or the hospital.
CONCLUSIONS: Pediatric cardioplegia is associated with reduced intracellular diastolic calcium during arrest and reperfusion and more complete arrest during exposure in rat cardiomyocytes. Pediatric patients receiving pediatric cardioplegia had reduced troponin T release compared with those receiving adult cardioplegia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19379896     DOI: 10.1016/j.athoracsur.2009.02.067

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  25 in total

1.  Use of del Nido cardioplegia solution and a low-prime recirculating cardioplegia circuit in pediatrics.

Authors:  Richard M Ginther; Ronald Gorney; Joseph M Forbess
Journal:  J Extra Corpor Technol       Date:  2013-03

2.  Comparison of Del Nido and Blood Cardioplegia in Pediatric Patients Undergoing Surgical Repair for Congenital Heart Disease.

Authors:  Fatma Ukil Isildak; Yasemin Yavuz
Journal:  Pediatr Cardiol       Date:  2021-05-03       Impact factor: 1.655

3.  International pediatric perfusion practice: 2011 survey results.

Authors:  Brian Harvey; Kenneth G Shann; David Fitzgerald; Brian Mejak; Donald S Likosky; Luc Puis; Robert A Baker; Robert C Groom
Journal:  J Extra Corpor Technol       Date:  2012-12

4.  Production Standard and Stability of Compounded Del Nido Cardioplegia Solution.

Authors:  Luis M Pereira; Gregory S Matte; Peter Lutz; Alana Arnold; Al Patterson
Journal:  Hosp Pharm       Date:  2017-11-09

5.  Del Nido Cardioplegia-Not Just Kids Stuff.

Authors:  Linda B Mongero
Journal:  J Extra Corpor Technol       Date:  2016-06

Review 6.  Blood Versus Crystalloid Cardioplegia in Pediatric Cardiac Surgery: A Systematic Review and Meta-analysis.

Authors:  Konstantinos S Mylonas; Aspasia Tzani; Panagiotis Metaxas; Dimitrios Schizas; Vasileios Boikou; Konstantinos P Economopoulos
Journal:  Pediatr Cardiol       Date:  2017-09-25       Impact factor: 1.655

7.  Myocardial protection using del nido cardioplegia solution in adult reoperative aortic valve surgery.

Authors:  Robert A Sorabella; Hiro Akashi; Halit Yerebakan; Marc Najjar; Ayesha Mannan; Mathew R Williams; Craig R Smith; Isaac George
Journal:  J Card Surg       Date:  2014-05-26       Impact factor: 1.620

8.  Clinical comparative analysis of histidine-tryptophan-ketoglutarate solution and St. Thomas crystalloid cardioplegia: A 12-year study from a single institution.

Authors:  Ying-Zhong Lin; Jing-Bin Huang; Xiang-Wei Li; Xian-Ming Tang; Wei-Jun Lu; Zhao-Ke Wen; Jian Liang; Dian-Yuan Li; Hao Wang
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

9.  del Nido versus St. Thomas Cardioplegia Solutions: A Single-Center Retrospective Analysis of Post Cross-Clamp Defibrillation Rates.

Authors:  Shane T Buel; Carrie Whittaker Striker; James E O'Brien
Journal:  J Extra Corpor Technol       Date:  2016-06

10.  Sufficient myocardial protection of del Nido cardioplegia regardless of ventricular mass and myocardial ischemic time in adult cardiac surgical patients.

Authors:  Ji Seong Kim; Jin Hee Jeong; Sin Ju Moon; Hyuk Ahn; Ho Young Hwang
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.